Measurement of TSAb directly in serum using FRTL-5 cells
- 9 April 1988
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 11 (4) , 313-317
- https://doi.org/10.1007/bf03350157
Abstract
FRTL-5 cells were shown to be suitable for the measurement of thyroid stimulating antibody (TSAb) present in sera of patients with Graves’ disease. Current methods for the assay of TSAb require the separation of immunoglobulin G (IgG)from patient sera. In this report the possibility to measure TSAb directly on serum was evaluated using FRTL-5 cells. To this purpose cells were seeded in 96-well plates and cultured for 4 days in medium deprived of TSH. Using this system bovine TSH was able to produce a significant stimulation of cAMP production at 1 μU/ml. Whole normal serum completely inhibited the stimulation of TSH as well as that of TSAb, while diluted serum was devoid of any effect. Heat inactivated sera and IgGs, prepared by DEAE Sephadex separation, were diluted in hypotonic medium and incubated with cells for 1 h at 37 C. After incubation cAMP was measured in the assay medium by RIA. In some experiments the effects of graded dilutions of sera and IgGs with known TSAb activity were compared. Sera as well as IgGs increased the cAMP production, but, at the highest concentrations, an inhibitory effect was evident. For this reason sera were tested after appropriate dilution. Thirteen/27 (48%) sera and 22/27 (81%) IgGs from patients with Graves’ disease were TSAb positive. The effect of Graves’ sera on adenylate cyclase stimulation was completely inhibited by an anti-human IgG. The results of stimulation produced by Graves’ sera and IgGs were highly correlated (r = 0.97, p < 0.001 ). In conclusion it is possible to measure TSAb directly in serum using FRTL-5 cells. This assay is less sensitive then the assay that employs the purified IgG. However, positive results were found in almost 50% of unselected Graves’ patients. Thus, it is reasonable to propose this assay as a first-line screening for TSAb; the assay employing purified IgGs can be limited to negative sera.Keywords
This publication has 11 references indexed in Scilit:
- Stimulation of thyroid adenylate cyclase activity by sera from patients with non-thyroidal illnessActa Endocrinologica, 1986
- Characterization of the Optimal Stimulatory Effects of Graves’ Monoclonal and Serum Immunoglobulin G on Adenosine 3′,5′-Monophosphate Production in FRTL-5 Thyroid Cells: A Potential Clinical AssayJournal of Clinical Endocrinology & Metabolism, 1983
- Heterogeneity of the Graves' Immunoglobulins Directed toward the Thyrotropin Receptor-Adenylate Cyclase System*Journal of Clinical Endocrinology & Metabolism, 1983
- Graves’ IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assayJournal of Endocrinological Investigation, 1982
- A New in Vitro Assay for Human Thyroid Stimulator Using Cultured Thyroid Cells: Effect of Sodium Chloride on Adenosine 3′,5′-Monophosphate Increase*Journal of Clinical Endocrinology & Metabolism, 1982
- Thyroid-Stimulating ImmunoglobulinsHormone Research, 1982
- Carbimazole and the Autoimmune Response in Graves' DiseaseNew England Journal of Medicine, 1980
- Culture of hormone-dependent functional epithelial cells from rat thyroids.Proceedings of the National Academy of Sciences, 1980
- VALUE OF THYROID-STIMULATING-ANTIBODY DETERMINATIONS IN PREDICTING SHORT-TERM THYROTOXIC RELAPSE IN GRAVES' DISEASEThe Lancet, 1977
- Isolation and Identification of the Long-Acting Thyroid Stimulator and Its Relation to Hyperthyroidism and Circumscribed Pretibial Myxedema1Journal of Clinical Endocrinology & Metabolism, 1964